findmyKOL
Clinical trialNCT03847571UnknownObservational

Acetazolamide (AZ) for Management of Alkalosis in Bartter Syndrome

SponsorTehran University of Medical SciencesEnrollment20Bartter Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In this prospective controlled cross over clinical trial, the investigators aim to evaluate the efficacy and safety of acetazolamide for the management of metabolic alkalosis in children with Bartter syndrome. Urine and blood electrolytes will be measured before and after acetazolamide treatment. The primary end point is a change in polyuria, hypokalemia, and metabolic alkalosis.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Iran
  • Fateme Ghane Sharbaf

    Mashhad, Iran

    Recruiting
  • Semnan University of Medical Sciences

    Semnan, Iran

    Recruiting
  • Banafshe Dormansh

    Tehran, Iran

    Not, yet, recruiting
  • Simin Sadeghi

    Zahedan, Iran

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Acetazolamide →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Jan 2019
Primary completion
30 Oct 2019
Completion
30 Dec 2019
Last update posted
20 Feb 2019
Registered enrollment
20
Registry id
NCT03847571
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.